srx-251
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2007 (NCT00461370)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Vasopressin V1a receptorANTAGONIST
AVPR1A antagonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545146 ↗
Also known as
- srx251
- srx251
- srx-251
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00532467 | Phase 1 | Sep 1, 2007 | Advanced Biomedical Research, Azevan Pharmaceuticals |
| NCT00461370 | Phase 1 | Apr 1, 2007 | Advanced Biomedical Research, Azevan Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Advanced Biomedical Research | For profit | 2 | 0 | 1 | 2007 |
| Azevan Pharmaceuticals | For profit | 2 | 2 | 1 | 2007 |
2 organizations
Page 1 / 1